BMS multiple myeloma BCMA CAR-T was accepted by the FDA and awarded priority review.
Tiantian Bio and MorphoSys announced that TJ210/MOR210 has been approved by the FDA for clinical trials.
FDA approves KALYDECO (ivacaftor) as the first and only CFTR regulator to treat children with cystic fibrosis.
The first HES biotherapy! GSK's Nucala is approved by the FDA.
The FDA's breakthrough therapy has determined that the listing of Regency BioTerripri single
New Crown Outbreak: 23.58 million! FDA grants emergency use authorization (EUA) for recovery plasma to treat hospitalized COVID-19 patients!
FDA releases draft guidelines for drug development for acute myeloid leukemia: Key points for targeted drug considerations.
Treatment of glioma The FDA grants pan-PI3K inhibitor paxalisib fast-track eligibility.
Imported soybeans have covered China's mainstream soybean pressing enterprises.
The clinical application for the treatment of R/R ENKTL by cornerstone pharmaceutical company PD-L1 antibody is approved by fda review in the United States.
New Crown Outbreak: 24.33 million! FDA grants Abbott COVID-19 antigen test card emergency use authorization: $5, 15 minutes out!
The first new mechanism acne drug in 40 years! Local androgen inhibitor Winlevi emulsion approved by FDA!
Treatment of specific non-small cell lung cancer patients Merck MET inhibitors in Germany was reviewed by the FDA as a priority.
FDA's latest article: The quality and origin of the drug does not matter.
DMD Innovative Therapy, which is eligible for FDA Priority Review, is expected to be approved in February next year.
Eye performance for the treatment of cysteine deposition FDA approved the first cysteine eye drops.
Swedish scientists have found that plant pigmented loin inhibits inflammation.
New drugs approved by the FDA from January to August 2020.
by the FDA Breakthrough Therapy: Treatment of Nasopharyngeal Cancer!
$5, 15 minutes out... Abbott's portable new crown detection card is authorized by the FDA for emergency use.